Showing 20 of 123 recruiting trials for “Systemic lupus erythematosus”
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
👨⚕️ bicheng Liu, Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine📍 1 site📅 Started Nov 2025View details ↗
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
RecruitingNCT06795893 ↗
The Anifrolumab PRIM Program
Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
👨⚕️ Jianhua Mao, MD, Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Nov 2025View details ↗
Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting
RecruitingNCT07352332 ↗
Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE
🏥 The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Sep 2025View details ↗
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Safety and Efficacy Study of CC312 for Moderate to Severe SLE
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Jul 2025View details ↗
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →